Antibody responses (as measured by radioimmunoassay), alterations in serum levels of complement, and the presence of circulating immune complexes (as measured by the fluid-phase CIQ-binding assay, the fluid-phase conglutinin assay, and the activation of Cl were evaluated in 15 children after meningitis and/or bacteremia caused by Streptococcuspneumoniae. The ages of the children ranged from two months to 16 years; the duration of follow-up ranged from 18 to 189 days (mean, 78 days). Increases in levels of homotypic antibody were found in only three (25070) of the 12 children in whom this response could be assessed, and all of these responses were transient. Eight (53070) of the 15 children had evidence of a heterotypic antibody response to S pneumoniae serotypes other than those causing their infections. The activation of Cl and Clq-binding activity were detected at the early stage of disease and were generally transient. The result of the fluid-phase conglutinin assay was positive for 14 (93070) of the 15 children later in the course of disease; this result was consistently positive throughout the followup period in the majority of children. Depressed concentrations of C4 were noted in nine children, depressed levels of C3 in four, and depressed levels of factor B in two.
titers of antibody in response to immunization with the capsular polysaccharides of Haemophi/us influenzae type b [4] , Neisseria meningitidis groups A and C [5, 6] , and S pneumoniae [7] . In addition, serologic responses to meningitis caused by H influenzae type b [8] , pneumonia caused by .Streptococcus pyogenes [9] , and otitis media [10] and pneumonia [11] caused by S pneumoniae are also weak in children less than two or three years of age. The immunologic responses of children to meningitis and primary bacteremia caused by S pneumoniae have not been defined.
Studies of serologic responses to pneumococcal infections in adults have demonstrated the need to consider the presence in serum of pneumococcal capsular polysaccharide (PCP) antigens that might interfere with antibody detection [12] . Theoretically, this circulating antigen may bind with antibody to form immune complexes, and levels of detectable antibody may thus be reduced. Circulating immune complexes may also play a pathogenic role; they have been associated with the development of glomerulonephritis [13, 14] and pulmonary alveolitis [13] in adults recovering from pneumococcal infections. The presence of circulating immune complexes in children with severe pneumococcal infections has not been reported.
The role of complement in the defense against pneumococcal infections has recently been reviewed [15] . A relation between depressed concentrations of serum complement components and an unfavorable outcome of pneumococcal infections has been observed in various experimental animal models [16] [17] [18] [19] as well as in naturally infected adults [12, [20] [21] [22] [23] . This relation has not been reported in children infected with S pneumoniae.
The present study was designed to evaluate the antibody responses, alterations in complement components, and presence of immune complexes in children after serious pneumococcal infections.
Materials and Methods
Population. The population studied consisted of infants and children whose bacteriologically confirmed bacteremia and/or meningitis caused by S pneumoniae was treated at The Hospital for Sick Children in Toronto. These patients were enrolled in this study after written, informed consent had been obtained from their parents. All patients were clinically monitored throughout their hospitalizations. Serial samples of serum were obtained from the patients and were stored in small aliquots at -70 C. The initial acute-phase serum sample was obtained within 48 hr of bacteriologic confirmation of S pneumoniae infection. Subsequent samples were obtained after the completion of antimicrobial therapy and then at two-to fourweek intervals for as long as 27 weeks.
Serotyping. Serotyping was performed by Dr J. M. S. Dixon (Provincial Laboratory, University of Alberta, Edmonton) by the capsular reaction (quellung) test with sera from Statens Seruminstitut in Copenhagen. Strains reacting with groupspecific antisera were subsequently typed with single-factor sera by Dr J. Henrichsen in Copenhagen; in these instances the type was recorded as a numeral followed by a capital letter, in accordance with Danish nomenclature.
Serologic studies and measurement of immunoglobulin levels. Antibody to PCP was measured by the RIA technique developed by Schiffman et al [24] , in which biosynthetically radiolabeled [14C]capsular polysaccharide antigens are used. Concentrations of antibody to the infecting serotype and to serotypes 3, 7, and 8 were determined Prober et al and expressed as nanograms of antibody nitrogen per milliliter (ng Ab N/ml). If the infecting serotype was 6A or 6B, concentrations of antibody to serotype 6A were always measured since these two subtypes are immunologically crossreactive [25] . As an assurance of uniform sensitivity of the assays on each trial, three reference sera with known quantities of specific antibody were included in each trial as internal controls.
Serum levels of IgG, IgA, IgM, C4, and C3 were determined by nephelometry with an automated Hyland Disc 120 nephelometer (Hyland Diagnostics, Costa Mesa, Calif). Concentrations of factor Band Cl-esterase inhibitor were estimated by radial immunodiffusion with use of commercial immunoplates (Behring Diagnostics, Montreal). The normal range for C3 was 90-160 mg/dl; for C4, 16-50 mg/dl; for factor B, 12-26 mg/dl; and for C1-esterase inhibitor, 14-34 mg/dl.
Immune complex assays. When necessary, serial samples of serum that had been frozen at -70 C were delipidated before use by vigorous mixing with an equal volume of trichlorotrifluoroethane and centrifugation at 1,500 g for 20 min. Three assays were used for assessment of the presence of circulating immune complexes.
The fluid-phase Clq-binding assay (ClqBA) was performed as described by Zubler and Lambert [26] . In brief, 50~l of test serum was mixed with 100~l of 0.2 M EDTA (pH 7.5) and incubated for 30 min at 37 C. Tubes were cooled at 4 C, and 50~l of [ 125I]Clq was added. Immune complexbound [125I]Clq was then precipitated by the addition of 3070 polyethylene glycol (PEG) and centrifugation. The radioactivity of the pellets was counted in a gamma counter (Minigamma; LKB, Hicksville, NY).
Human IgG was purified by ammonium sulfate precipitation and ion-exchange chromatography. The IgG was aggregated at 10 mg/ml for 20 min at 63 C. Various concentrations of heat-aggregated IgG (HAGG) were used in the construction of a standard curve. Values (mean + 2 SD) obtained for 25 normal individuals were <100~g equivalents of HAGG/ml of serum.
The fluid-phase conglutinin assay (KgBA) was performed according to Macanovic and Lachmann [27] . In brief, 100~l of test serum, diluted 1:4 in Tween-borate buffer (pH 8.3) containing 10 roM CaCI 2, was allowed to react with [ 125I]con_ glutinin for 1 hr at 4 C. Immune complex-bound conglutinin was precipitated with 0.5 ml of a 4070 solution of PEG. The radioactivity of the pellets obtained after centrifugation was measured in a gamma counter. For the construction of a standard curve, aliquots of normal human serum incubated at 37 C for 30 min with concentrations of HAGG varying from 10 to 1,000 j.Lg/ml were used. The test gave a positive result when values were >10 j.Lg equivalents of HAGG/ml of heated serum (mean of 25 normal samples + 2 SD).
Activation of Cl (CIA) was analyzed by double diffusion in agarose as described by Ziccardi and Cooper [28] . Monospecific antisera to Clq, Cr, and CIs (Atlantic Antibodies, Scarborough, Me) were used.
Results
Patients and clinical course. Fifteen children were enrolled in this study during the seven-month period from March to October 1981. Their ages, underlying diseases, sources of positive cultures, and clinical courses are summarized in table 1. The ages of the children ranged from two months to 16 years (mean, five years). Six children were less than two years old. Four children had underlying diseases (Alagille's syndrome, sickle cell disease, brain tumor, and congenital heart disease with probable asplenia). Eleven patients had meningitis, and four had bacteremia without meningitis. Only one patient had received antibiotics prior to admission. All received penicillin for their infections. The follow-up period ranged from 18 to 189 days (mean, 78 days). Three of the 15 patients had an unfavorable clinical course. One (a 12-month-old, previously normal girl) developed renal failure, severe hepatic dysfunction, disseminated intravascular coagulation, coma, and secondary Pseudomonas aeruginosa septicemia during her hospitalization for S pneumoniae meningitis and bacteremia. Another previously normal child (a 36-month-old boy) developed evidence of brain edema and cerebral infarcts with occipital blindness during his hospitalization for S pneumoniae meningitis and bacteremia. A third child (a 20-month-old girl) with congenital heart disease and probable asplenia developed renal failure, severe hepatic dysfunction, shock, and disseminated intravascular coagulation during her hospitalization for S pneumoniae bacteremia. No patient developed a rash, arthritis, pneumonitis, hypertension, or gross hematuria.
Antibody response. The serotypes of S pneumoniae causing the infections were type 3 (one infection), type 6A (one), type 6B (four), type 8 (one), type 9V (one), type 11 (one), type 14 (two), type 18C (one), type 23 (two), and type 24 (one).
Prober et of
The homotypic serologic response to infection in 12 patients is summarized in table 2. Data for patient 1 (infected with serotype 24) are not included because that specific antigen was not available for use in the RIA system. The sera of patients 11 and 15 (infected with serotypes 23 and 11, respectively) were lost prior to homotypic antibody determinations. An increase in specific antibody was defined as a titer rise of 40070 with a final concentration of >200 ng Ab N/ml. Only three (25070) of the 12 patients assessed had such an increase; this increase was transient in all three patients, lasting for <36, <42, and <96 days, respectively. Four patients who had initial concentrations of homotypic antibody of >200 ng Ab N/ml still developed an infection. The initial antibody concentrations and day of sampling relative to the initial assessment of these four patients were: patient 5, 276 ng Ab N/ml, day 1; patient 8, 820 ng Ab N/ml, day 4; patient 10,201 ng Ab N/ml, day 4; and patient 14, 445 ng Ab N/ml, day 5. The initial concentrations of specific antibody in the three patients who had unfavorable clinical courses were 15, 276, and 820 ng Ab N/ml, respectively. Two of these patients had a transient rise in levels of specific antibody.
The heterotypic antibody responses of the 15 patients are summarized in table 3. There were three heterotypic responses to serotype 3, three to serotype 7, and seven to serotype 8. At least one heterotypic response was noted in eight (53070) of the 15 patients. All patients had normal concentrations of IgG, IgA, and IgM on admission to the hospital. In 12 patients, concentrations of total serum IgG increased after admission to the study. The increase ranged from 1.1-to 2.4-fold (mean, 1.5-fold). In the three patients who had a homotypic antibody response, IgG concentrations increased 1.3-fold, 1.9-fold, and twofold, respectively. 431 Total serum IgA concentrations increased in six patients. The increase ranged from 1.1-fold to sixfold (mean, 2.6-fold). In 10 patients, total serum IgM concentrations increased by 1.2-to 2.4-fold (mean, 1.8-fold). IgM concentrations did not increase in two of the three patients who had a homotypic antibody response; in the third patient, the level of IgM rose by 1.9-fold.
Circulating immune complexes. The detection of circulating immune complexes is summarized in table 4. Immune complexes were detected in 14 patients by the KgBA and in 12 patients by either the CIA or the C1qBA. In eight cases, C1 was activated without a reduction in levels of C1-esterase inhibitor. In four cases, the C1qBA gave a positive result. The maximal level of complexes detected by the KgBA ranged from 0.031 to 0.295 Jig equivalents of HAGG/ml of serum '(mean, 0.148). Activation of C1 and C1q-binding activity were usually detected in early samples, whereas the KgBA generally gave a positive result for later samples. The duration of the presence of circulating immune complexes ranged from four days to more than 132 days; in 12 patients, complexes were detected at the last follow-up visit. In the majority of samples containing immune complexes, levels of C4 and C3 were depressed. (See next section.) No significant correlation between the presence of circulating immune complexes and levels of the three major classes of polyclonal immunoglobulins was found; neither was a correlation between the presence of complexes and levels of homotypic antibodies noted. The three patients whose clinical course was unfavorable could not be differentiated from the other patients on the basis of immune complex detection.
Complement changes. Four patients had depressed levels of C3 (14-66 mg/dl); nine had depressed levelsof C4 (2-14 mg/dl), and two had depressed levels of factor B (5 and 7 mg/dl; respectively). The three patients whose clinical course was unfavorable could not be distinguished from the other patients in terms of complement component depression.
Discussion
Several studies of adult populations suggest that pneumococcal polysaccharide vaccines are antigenic [29] and result in protection against S pneumoniaeinfections [30, 31] . In children, the immunogenicity of these vaccines is much less consistent and is dependent on age and serotype (7, 32] . The poorest responses are noted in the youngest children. The protective effect of the vaccines in children is also markedly age dependent [32] . Data on the antigenicity and protective effects of natural S pneumoniae infections in adults are quite limited. Type-specific antibody responses to pneumococcal pneumonia have been noted to be extremely variable [33] and often transient [34, 35] . These transient responses have been associated with recurrences of pneumonia [34, 35] . In a recent study of 18 adults with pneumococcal pneumonia, the peak concentration of antibody to PCP (as measured by RIA) ranged from 27 to 2,168 ng Ab N/ml, with concentrations of >200 ng Ab N/ml in only 33070 of the patients [12] .
Data on the antigenicity of natural S pneumoniae infections in children are limited to the study of antibody levels attained after otitis media and pneumonia. In one study, only 25070 of 61 children with otitis media had a rise in titer of homotypic pneumococcal antibody after their infection [lO] . The response rate was age dependent: 48070 among children over two years of age but only 12070 among children under one year of age. A similar relation between age and antibody response was observed among 116 children with pneumococcal pneumonia [11] . The low-numProber et at bered serotypes were the most antigenic in the latter study.
Our study is the first to address the antigenicity of S pneumoniae meningitis and primary bacteremia in children. Only three (25070) of the 12 children assessed had a significant rise in the titer of homotypic antibody, and all three of these increases were transient (table 2) . The recent description by Cole et al of eight episodes of recurrent systemic S pneumoniae infection in immunologically normal children supports the lack of protective immunity after infections with this organism [36] . Possible explanations for these poor immunologic responses include: (1) a defect in antigen processing by mononuclear phagocytes [36] ; (2) a primary developmental defect in immunoglobulin synthesis in B lymphocytes [36] ; (3) inadequate levels of preexisting type-specific antibody to serve as an immunologic "primer" [37] ; (4) low levels of IgG2 during infancy [38] ; (5) early antibiotic treatment (which has been noted to affect immune responses to S pyogenes infection) [39] ; (6) a higher level of suppressor T-cell activity in children than in adults [40] ; and (7) "immune paralysis," as noted in the mouse model studied by Felton et al [41] . In the latter model, large doses of pneumococcal polysaccharide resulted in longlasting and total inhibition of the ability to produce neutralizing antibodies. This theory is also supported by the data of Dee et al [12] , who noted poor serologic responses in adults who had high circulating concentrations of PCP antigen. The mechanism of this "immune paralysis" may be the formation of complexes by available antibody and circulating antigen. Although we did not assay for circulating antigen, we did observe evidence of circulating immune complexes in all patients at some time during follow-up. These complexes persisted in many patients beyond the last followup visit (table 4) . Four of 12 patients in whom initial concentrations of specific antibody were assessed had levels of >200 ng Ab N/ml; two of these four patients had initial concentrations of >300 ng Ab N/ml. Although the exact antibody level that is "protective" is difficult to define and may vary slightly from serotype to serotype, data for persons in whom vaccination has failed to prevent infection have indicated that levels of 250-300 ng Ab N/ml after immunization are probably protective [42] .
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The fact that two of our patients had antibody concentrations of 445 and 820 ng Ab N/mI five and four days, respectively, after admission to the hospital with S pneumoniae infection, may indicate that a rapid serologic response occurred or that a concentration of antibody in excess of these amounts is necessary for consistent protection from infection. Naturally occurring antibody may have a lower level of biologic activity than antibody elicited by immunization.
In eight patients, we observed evidence of heterotypic antibody responses (table 3) . These heterotypic responses had previously been noted in eight of 116 children with pneumococcal pneumonia [11] . The high degree of specificity of the RIA for antibody [43, 44] makes nonspecific reactions an unlikely explanation for these heterotypic responses. Possible explanations include: (1) multiple infections in the same patient; (2) mild or inapparent infections with other serotypes; (3) antigenic cross-reactions among pneumococcal serotypes that are perhaps unmasked during natural infection; and (4) the induction of a polyclonal IgG response by pneumococcal infection. This last explanation is supported by the frequently high concentrations of IgG and IgM in our patients.
Circulating immune complexes have been found in patients with both complicated [13, 14] and uncomplicated forms of pneumococcal disease (G.S., unpublished observations). In complicated cases, these immune complexes have been associated with acute glomerulonephritis [13, 14] and pulmonary alveolitis [13] . The complexes have been shown to contain pneumococcal antigen and antibody, C3, and immunoglobulins. Positive immunofluorescence for pneumococcal antigen has been noted in kidneys and lungs [13] . Although none of our patients had clinical evidence of immune complex-mediated illness (rash, arthritis, glomerulonephritis, or alveolitis), all had measurable complexes at some point.
Activation of Cl and Clq-binding activity were detected at the early stage of disease and were generally transient. The assays used best detect immune complexes in slight antigen excess but are not very sensitive. The KgBA is more efficient in detecting low levels of circulating immune complexes formed in antibody excess that have activated C3 through the classical or the alternate pathway of complement. Therefore, a delayed 433 positivity of the results of this assay in the course of the disease is not surprising. The persistence of circulating immune complexes detected by the KgBA in our patients may have been due to the persistence of the antigen or of a cross-reacting antigen. Alternatively, immune complexes may have been induced by concomitant and unrecognized infections. The persistence of circulating immune complexes may have contributed at least partially to the poor antigenicity of the S pneumoniae infections. The measurement of concentrations of homotypic antibody in our patients after the circulating immune complexes have cleared will be of interest.
We have described the immunologic responses of children to serious S pneumoniae infections.
These children had uniformly poor homotypic antibody responses to the infecting serotypes. Heterotypic responses were noted quite frequently, however. Some degree of immune complex formation was noted in every patient at some time during follow-up. These immune complexes were generally detected at low concentrations and were not correlated with the clinical course of infection. Evidence of complement activation was noted in many of our patients and also bore no relation to the clinical course.
